NTx Bio Powers Baylor College of Medicine’s Manufacturing of a Personalized Cancer Vaccine in Diakonos Oncology’s Phase 1 Refractory Melanoma Trial
NTx Bio, a leader in next-generation biomanufacturing technologies, announced that its NTxscribe® CORE platform is being used by researchers at Baylor College of Medicine to manufacture mRNA for a personalized dendritic cell vaccine (DCV) now in clinical use in an industry-sponsored Phase 1 trial for refractory melanoma, marking one of the first publicly disclosed clinical translations of NTx’s continuous-flow manufacturing platform.
BioSkryb Genomics Names William E. Evans, Pharm.D. as Chief Executive Officer
BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of its Scientific Advisory Board since 2019. He succeeds Suresh Pisharody, who has departed the company to pursue other opportunities.
Niron Magnetics Receives $150 Million Loan From the Shakopee Mdewakanton Sioux Community to Support Iron Nitride Magnet Manufacturing
Niron Magnetics, the company commercializing the world’s first rare-earth-free Iron Nitride permanent magnets, announced a $150 million loan from the Shakopee Mdewakanton Sioux Community (SMSC) to advance the construction of its Sartell, Minnesota, magnet manufacturing plant.
Euro Manganese Signs Offtake Term Sheet with 6K Energy Following Preliminary Qualification of High-Purity Manganese
Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (OTC Pink: EUMNF) (FSE: E060) (the “Company” or “Euro Manganese” or “EMN”) is pleased to announce that it has entered into a non-binding offtake term sheet with 6K Energy, a leading U.S.-based producer of advanced cathode active materials (“CAM”), for the proposed sale of high-purity electrolytic manganese metal (“HPEMM”) from the Company’s Chvaletice Manganese Project (“Chvaletice” or the “Project”) in the Czech Republic.
Niron Magnets Receives Conditional $150 Million Department of War Commitment
Niron Magnetics, the company commercializing the world’s first rare-earth-free Iron Nitride permanent magnets, today announced a conditional commitment from the Department of War’s Office of Strategic Capital (OSC) for a direct loan of up to $150 million with a 20-year term to support construction and equipment for the company’s advanced manufacturing plant in Sartell, Minnesota. The financing would accelerate domestic production of Niron’s proprietary Iron Nitride permanent magnets, which do not require rare earth materials, and would expand domestic production of advanced permanent magnets.
ai& Collaborates with Voltaiq to Ensure Quality, Reliability, and Safety of Battery Energy Storage for AI Data Centers
ai& (“ai-and”), a vertically integrated frontier AI technology company, and Voltaiq, the leading Enterprise Battery AI company, today announced plans to deploy battery energy storage systems (BESS) across ai&’s AI data centers in Japan, backed by Voltaiq’s unique AI-powered platform for tracking and ensuring battery quality and safety across the full lifecycle, spanning selection, integration, deployment, and operation.